Policy, Drug Costs, & Financial Stability of Health Systems
Stabilizing the Pharmaceutical Supply Chain
Patients as Consumers of Healthcare
Realizing the Potential of Therapeutic Advances
Environmental Sustainability and Resilience: A Strategic Imperative for Pharmacy Leaders
100

The acronym for Pharmacy Benefit Manager.

What is a PBM?

100

___ is a growing concern for pharmaceutical supply chain.

What is Cybersecurity?

100

Form of contactless health care.

What is Telehealth services?

100

___ involves the integration of diagnostic and treatment strategies into a singular approach.

What is Theranostic?

100

Extreme heat, wildfires, floods, and hurricanes are called climate ____.

What are hazards?

200

The "spill-over" effect will result in an overall ____ health-system pharmacy revenue.

What is decrease?

200

Pharmacy leaders should demand more supply chain ____ and accountability from industry partners.

What is transparency?

200

It is predicted that most patients will view ___ as an enhancement to care.

What is AI?

200

___ remains a serious global health issue, affecting close to 1 billion people around the world.

What is obesity?

200

This strategy reduces healthcare emissions by using renewable energy, improving efficiency, lowering transportation emissions, and selecting lower emission medications.

What is decarbonization?

300

It is somewhat/very likely that 50% of health systems will contract with a ______ Pharmacy Benefit Manager (PBM).

What is transparent?

300

Pharmacists are near the ____ of the supply chain.

What is end?

300

These types of laws are predicted by less than half panelists to be overturned by the US Supreme Court, raising concern for legal risks when seeking/providing care across state lines.

What are shield laws?

300

___ remains the only pathogen fully eradicated.

What is smallpox?

300

_____ is becoming the seventh dimension of healthcare quality.

What is sustainability?

400

Recommendations for Pharmacy Leaders, according to the article. (Name 1 of 4)

What is

  • Create advocacy agenda?

  • Assess vulnerabilities and financial impact?

  • Meet regularly with government relations?

  • Align with executives on medication access strategy?

400

71% of panelists indicated that federal policy was likely to incentivize this type of sector drug manufacturing.

What is private-sector?

400

Health-system financial pressures will ____ the adoption and access to technologies that have the potential to transform patient care.

What is limit?

400

GLP-1 RAs have demonstrated great promise in weight loss reduction for many individuals, up to ___%.

What is 15%?

400

The number one cause of weather-related death is ____.

What is extreme heat?

500

The result of an increase to the share adjustment percentage (from 11.75% to 20%) on 340B-eligible disproportionate share hospitals (DSHs).

What is decrease in 340B-eligible disproportionate share hospitals (DSHs)?

500

Health-system leaders should leverage partnerships to coordinate with ___, wholesalers, and manufacturers.

What are group purchasing organizations (GPOs)?

500

It is predicted that limitations on these types of contract pharmacies would reduce the scope and number of programs that are targeted to improve access for a community's underserved patients.

What are 340B contract pharmacies?

500

Health-system leaders must partner with ___to develop vaccine promotion program.

What is nonpublic health organization?

500

This is the percentage of total U.S. greenhouse gas emissions contributed by the healthcare system.

What is 8.5%?

M
e
n
u